Clinical study of living skin replacement to help wound healing: 

            The name is Vitrix. This cellular dermal replacement involves living human dermal cells (fibroblasts) and the dermal structural protein collagen. Vitrix can be folded and inserted into deep wounds like those caused by diabetic foot ulcers. About 800,000 people worldwide suffer from this problem and it accounts for 50,000 amputations a year. Organogenesis Inc., Canton, Massachusetts as part of its clinical study will administer Vitrix to 20 patients with diabetic foot ulcers. If the ulcers do not heal within 12 weeks, the patients will receive Apligraf. Apligraf is different from Vitrix in that it is an actual cellular skin substitute consisting of living human epidermal cells, called keratinocytes, along with the dermal cells and collagen present in vitrix. For more details check out www.organogenesis.com